Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc.
Your view on TCMD
Overview
What the company does, where it operates, and who runs it.
About Tactile Systems Technology, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Sheri Louise Dodd
- Headquarters
- 3701 Wayzata Boulevard, Minneapolis, MN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Sheri Louise Dodd
- Headquarters
- 3701 Wayzata Boulevard, Minneapolis, MN, US
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States.
The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Tactile Systems Technology, Inc., and the rating behind it. TCMD last traded at $22.40, 20.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Tactile Systems Technology, Inc.. Starting points for Tactile Systems Technology, Inc.: P/E 20.5, EPS $1.10, beta 0.79 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Tactile Systems Technology, Inc.. Tactile Systems Technology, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Tactile Systems Technology, Inc.. Trailing twelve-month EPS for Tactile Systems Technology, Inc. stands at $1.10. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Tactile Systems Technology, Inc.. Tactile Systems Technology, Inc. has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Tactile Systems Technology, Inc. valued side by side against its closest peers. Tactile Systems Technology, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Tactile Systems Technology, Inc., and how their positions are changing. At a $505.3M market value, institutional positions materially move Tactile Systems Technology, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Tactile Systems Technology, Inc. executives and directors. Shares of Tactile Systems Technology, Inc. have traded between $8.61 and $25.41 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Tactile Systems Technology, Inc.. Tactile Systems Technology, Inc. is a $505.3M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Tactile Systems Technology, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Tactile Systems Technology, Inc.. Coverage tracks Tactile Systems Technology, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.